Sharekhan

Innova Captab Ltd

Fri 22/05/2026,15:59:15 | NSE : INNOVACAP

₹ 848.30-23.95 (-2.75%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 868.50

Previous Close

₹ 872.25

Volume

33510

Mkt Cap ( Rs. Cr)

₹4854.39

High

₹ 891.50

Low

₹ 841.20

52 Week High

₹ 1020.70

52 Week Low

₹ 622.00

Book Value Per Share

₹ 185.81

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Innova Captab Ltd

Your Vote -

Buy

60.00%

Hold

0.00%

Sell

40.00%

60.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

848.30

1

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1

Option Chain

Analyzes market sentiment, predicts Innova Captab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 May 2026, 5:41PM Pursuant to Regulation 30 read with Schedule III (Part A) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements),
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    20 May 2026, 5:41PM Innova Captab Limited has informed the Exchange about Schedule of meet
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    14 May 2026, 5:11PM Innova Captab Limited has informed the Exchange about Transcript
  • Innova Captab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    14 May 2026, 5:08PM This is in continuation to our letter dated 08th May, 2026, wherein we had informed regarding the audio link of the earnings call with analysts/invest
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    8 May 2026, 6:04PM This is further to our intimation letter dated 30th April, 2026, and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Reg
  • Innova Captab - Copy of Newspaper Publication

    8 May 2026, 5:54PM Innova Captab Limited has informed the Exchange about Copy of Newspaper Publication
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    8 May 2026, 5:48PM Innova Captab Limited has informed the Exchange about Link of Recording
  • Innova Captab - Announcement under Regulation 30 (LODR)-Investor Presentation

    7 May 2026, 7:29PM This is in continuation to our dated 30th April, 2026 wherein we had informed regarding an earnings call Scheduled to be held on Friday 08th May, 2026
  • Innova Captab - Investor Presentation

    7 May 2026, 7:25PM Innova Captab Limited has informed the Exchange about Investor Presentation
  • Innova Captab - Press Release

    7 May 2026, 6:47PM Innova Captab Limited has informed the Exchange regarding a press release dated May 07, 2026, titled ""Press Release"".
  • Innova Captab - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    7 May 2026, 6:47PM Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Press Release iss
  • Innova Captab - Outcome Of The Board Meeting Held Today I.E. 07Th May, 2026

    7 May 2026, 6:00PM Pursuant to regulation 30 (read with part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements)
  • Innova Captab - Outcome of Board Meeting

    7 May 2026, 5:34PM Innova Captab Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Innova Captab Q4 net profit up 23.53% at Rs 21.16 cr

    7 May 2026, 5:10PM The company reported standalone net profit of Rs 21.16 crore for the quarter ended March 31, 2026 as compared to Rs 17.13 crore in the same period las
  • Innova Captab - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th May, 2026

    7 May 2026, 4:50PM Pursuant to regulation 30 (read with Part A of Schedule III) and other applicable provisions of\r\nSEBI (Listing Obligations and Disclosure Requiremen
  • Innova Captab - Disclosure under SEBI Takeover Regulations

    4 May 2026, 10:50PM Innova Captab Limited Meenaÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (S
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Apr 2026, 12:10PM Innova Captab Limited has informed the Exchange about Schedule of meet
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Apr 2026, 12:09PM Pursuant to the Regulation 30 read with Schedule III Part A - Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2
  • Innova Captab - Board Meeting Intimation for Intimation Of Board Meeting Under Regulations 29 Of The SEBI (LODR) Regulations,

    29 Apr 2026, 9:30PM Innova Captab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and ap
  • Innova Captab - Announcement under Regulation 30 (LODR)-Credit Rating

    14 Apr 2026, 6:50PM Intimation under regulation 30 of SEBI (LODR), 2015 regarding credit rating.
  • Innova Captab - Credit Rating

    14 Apr 2026, 6:46PM Innova Captab Limited has informed the Exchange about Credit Rating
  • Innova Captab - Updates

    14 Apr 2026, 6:41PM Innova Captab Limited has informed the Exchange regarding 'Intimation under Regulation 30
  • Innova Captab - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015

    14 Apr 2026, 6:41PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure requirement) Regulations, 2015
  • Innova Captab has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    9 Apr 2026, 6:20PM As of March 2026, 50.90% is owned by Indian Promoters and 49.10% by Public. <p align=justify> Institutional holds 20.37% (Insurance Companies 1.22%) a
  • Innova Captab - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2026, 3:45PM Innova Captab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended 31 Ma
  • Innova Captab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2026, 3:42PM Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith a
  • Innova Captab - Trading Window

    25 Mar 2026, 7:13PM Innova Captab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Mar 2026, 3:17PM Innova Captab Limited has informed the Exchange about Schedule of meet
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Mar 2026, 3:19PM Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requireme

Key fundamentals

Evaluate the intrinsic value of Innova Captab Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1207.949 1140.093 964.502 503.507 386.882
Liabilities 1207.949 1140.093 964.502 503.507 386.882
Equity 57.225 57.225 57.225 48 12
Gross Profit 151.367 122.299 107.97 98.529 98.509
Net Profit 83.692 89.47 68.161 57.552 66.178
Cash From Operating Activities 34.106 19.801 111.674 39.279 58.339
NPM(%) 6.44 9.33 7.88 6.7 8.42
Revenue 1298.814 958.061 864.929 858.673 785.455
Expenses 1147.447 835.762 756.959 760.144 686.946
ROE(%) 7.87 8.41 6.41 5.41 6.22

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
30 Jan 2026 2 20 0 644.75

Peers

Other companies within the same industry or sector that are comparable to Innova Captab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 484.08 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 1763.94 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 11065.80 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 1663.44 -363.15 0.00

Company Info

Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.

Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.

Parent Organisation

Innova Captab Ltd.

Founded

03/01/2005

Managing Director

Mr.Vinay Kumar Lohariwala

NSE Symbol

INNOVACAPEQ

FAQ

OPEN FREE* DEMAT ACCOUNT